Development of an integrated conceptual model of multiple sclerosis spasticity

References

• Reich DS, Lucchinetti CF, Calabresi PA. Multiple sclerosis. N Engl J Med. 2018;378(2):169–180. doi: 10.1056/NEJMra1401483.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet. 2018;391(10130):1622–1636. doi: 10.1016/S0140-6736(18)30481-1.
   PubMed Web of Science ®Google Scholar
• Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029–e1040. doi: 10.1212/WNL.0000000000007035.
   PubMed Web of Science ®Google Scholar
• Bethoux F, Marrie RA. A cross-sectional study of the impact of spasticity on daily activities in multiple sclerosis. Patient. 2016;9(6):537–546. doi: 10.1007/s40271-016-0173-0.
   PubMedGoogle Scholar
• Barin L, Salmen A, Disanto G, et al. The disease burden of multiple sclerosis from the individual and population perspective: which symptoms matter most? Mult Scler Relat Disord. 2018;25:112–121. doi: 10.1016/j.msard.2018.07.013.
   PubMed Web of Science ®Google Scholar
• Norbye AD, Midgard R, Thrane G. Spasticity, gait, and balance in patients with multiple sclerosis: a cross-sectional study. Physiother Res Int. 2020;25(1):e1799. doi: 10.1002/pri.1799.
   PubMed Web of Science ®Google Scholar
• Bhimani R, Anderson L. Clinical understanding of spasticity: implications for practice. Rehabil Res Pract. 2014;2014:279175. doi: 10.1155/2014/279175.
   PubMedGoogle Scholar
• Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–1907. doi: 10.1007/s11135-017-0574-8.
   PubMed Web of Science ®Google Scholar
• Learmonth YC, Motl RW, Sandroff BM, et al. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013;13:37. doi: 10.1186/1471-2377-13-37.
   PubMed Web of Science ®Google Scholar
• Lance JW. Pathophysiology of spasticity and clinical experience with baclofen. In Lance JW, Feldman, R.G., Young, R.R. and Koella, W.P., editor. Spasticity: disordered motor control. Chicago: Year Book; 1980. p. 185–204.
   Google Scholar
• Pandyan AD, Gregoric M, Barnes MP, et al. Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27(1-2):2–6. doi: 10.1080/09638280400014576.
   PubMed Web of Science ®Google Scholar
• Paolucci S, Martinuzzi A, Scivoletto G, et al. Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the italian consensus conference on pain in neurorehabilitation. Eur J Phys Rehabil Med. 2016;52(6):827–840.
   PubMed Web of Science ®Google Scholar
• Dressler D, Bhidayasiri R, Bohlega S, et al. Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy. J Neurol. 2018;265(4):856–862. doi: 10.1007/s00415-018-8759-1.
   PubMed Web of Science ®Google Scholar
• Balantrapu S, Sosnoff JJ, Pula JH, et al. Leg spasticity and ambulation in multiple sclerosis. Mult Scler Int. 2014;2014:649390. doi: 10.1155/2014/649390.
   PubMedGoogle Scholar
• Milinis K, Young CA, Trajectories of Outcome in Neurological Conditions (TONiC) study. Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. Disabil Rehabil. 2016;38(15):1431–1441. doi: 10.3109/09638288.2015.1106592.
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Henze T, Zettl U. Spasticity in patients with multiple sclerosis–clinical characteristics, treatment and quality of life. Acta Neurol Scand. 2014;129(3):154–162. doi: 10.1111/ane.12202.
   PubMed Web of Science ®Google Scholar
• Zettl UK, Henze T, Essner U, et al. Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (move I). Eur J Health Econ. 2014;15(9):953–966. doi: 10.1007/s10198-013-0537-5.
   PubMed Web of Science ®Google Scholar
• Trojano M, Celius EG, Donze C, et al. Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights. Eur Neurol. 2014;72(Suppl 1):15–19. doi: 10.1159/000367619.
   PubMedGoogle Scholar
• Vermersch P. MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study. Neurodegener Dis Manag. 2014;4(6):407–415. doi: 10.2217/nmt.14.44.
   PubMedGoogle Scholar
• Cordeau D, Courtois F. Sexual disorders in women with MS: assessment and management. Ann Phys Rehabil Med. 2014;57(5):337–347. doi: 10.1016/j.rehab.2014.05.008.
   PubMedGoogle Scholar
• Meuth SG, Vila C, Dechant KL. Effect of sativex on spasticity-associated symptoms in patients with multiple sclerosis. Expert Rev Neurother. 2015;15(8):909–918. doi: 10.1586/14737175.2015.1067607.
   PubMed Web of Science ®Google Scholar
• Milinis K, Tennant A, Young C. Spasticity in multiple sclerosis: associations with impairments and overall quality of life. Mult Scler Relat Disord. 2016;5:34–39. doi: 10.1016/j.msard.2015.10.007.
   PubMed Web of Science ®Google Scholar
• Flachenecker P. Evolution of multiple sclerosis spasticity-associated symptoms: latest data. Neurodegener Dis Manag. 2016;6(6s):9–12. doi: 10.2217/nmt-2016-0047.
   PubMedGoogle Scholar
• Shaikh A, Phadke CP, Ismail F, et al. Relationship between botulinum toxin, spasticity, and pain: a survey of patient perception. Can J Neurol Sci. 2016;43(2):311–315. doi: 10.1017/cjn.2015.321.
   PubMed Web of Science ®Google Scholar
• Giacoppo S, Bramanti P, Mazzon E. Sativex in the management of multiple sclerosis-related spasticity: an overview of the last decade of clinical evaluation. Mult Scler Relat Disord. 2017;17:22–31. doi: 10.1016/j.msard.2017.06.015.
   PubMed Web of Science ®Google Scholar
• Maitin IB, Cruz E. Special considerations and assessment in patients with multiple sclerosis. Phys Med Rehabil Clin N Am. 2018;29(3):473–481. doi: 10.1016/j.pmr.2018.03.003.
   PubMed Web of Science ®Google Scholar
• Cheung J, Rancourt A, Di Poce S, et al. Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments. Physiother Can. 2015;67(2):157–166. doi: 10.3138/ptc.2014-07.
   PubMed Web of Science ®Google Scholar
• Rizzo M, Hadjimichael O, Preiningerova J, et al. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler. 2004;10(5):589–595. doi: 10.1191/1352458504ms1085oa.
   PubMed Web of Science ®Google Scholar
• Sweatman WM, Heinemann AW, Furbish CL, et al. Modified PRISM and SCI-SET spasticity measures for persons with traumatic spinal cord injury: results of a rasch analyses. Arch Phys Med Rehabil. 2020;101(9):1570–1579. doi: 10.1016/j.apmr.2020.05.012.
   PubMed Web of Science ®Google Scholar
• Fernández Ó, Costa-Frossard L, Martínez-Ginés M, et al. The broad concept of "spasticity-plus syndrome" in multiple sclerosis: a possible new concept in the management of multiple sclerosis symptoms. Front Neurol. 2020;11:152. doi: 10.3389/fneur.2020.00152.
   PubMed Web of Science ®Google Scholar
• Fisk JD, Pontefract A, Ritvo PG, et al. The impact of fatigue on patients with multiple sclerosis. Can j Neurol Sci. 1994;21(1):9–14. doi: 10.1017/S0317167100048691.
   PubMed Web of Science ®Google Scholar
• Kobelt G, Thompson A, Berg J, et al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123–1136. doi: 10.1177/1352458517694432.
   PubMed Web of Science ®Google Scholar
• Kister I, Bacon TE, Chamot E, et al. Natural history of multiple sclerosis symptoms. Int J MS Care. 2013;15(3):146–158. doi: 10.7224/1537-2073.2012-053.
   PubMedGoogle Scholar
• Hobart JC, Riazi A, Thompson AJ, et al. Getting the measure of spasticity in multiple sclerosis: the multiple sclerosis spasticity scale (MSSS-88). Brain. 2006;129(Pt 1):224–234. doi: 10.1093/brain/awh675.
   PubMedGoogle Scholar
• Langer-Gould AM, Gonzales EG, Smith JB, et al. Racial and ethnic disparities in multiple sclerosis prevalence. Neurology. 2022;98(18):e1818–e1827. doi: 10.1212/WNL.0000000000200151.
   PubMedGoogle Scholar
• Turner-Bowker DM, Lamoureux RE, Stokes J, et al. Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development. Value Health. 2018;21(7):839–842. doi: 10.1016/j.jval.2017.11.014.
   PubMed Web of Science ®Google Scholar